MLECMICRO

Moolec Science S.A.

HealthcareBiotechnology
$8.98
$0.00(+0.67%)
52W$0.20
$23.22
Updated May 8, 12:00 AM
RSI51
RS Rating99/99
Beta0.89
Volatility174%
F-Score4/9
Mkt Cap$7M
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

Moolec Science S.A. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is leading (RS Rating: 99), indicating clear outperformance against the broad market. Earnings contraction of 20% provides fundamental context to the price action. Investors should exercise caution due to high volatility (174% annualized), which requires wider risk management.

Relative Strength
99
out of 99
Market Leader
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
0.89
vs S&P 500
DEFENSIVE
52W Position
38%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$8.82
50 SMA > 100 SMA$7.69
100 SMA > 150 SMA$8.19
150 SMA > 200 SMA$13.49

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$8.34+7.64%ABOVE
50 SMA$8.82+1.85%ABOVE
100 SMA$7.69+16.72%ABOVE
150 SMA$8.19+9.66%ABOVE
200 SMA$13.49-33.41%BELOW

Price Performance

1D+0.7%
1W-20.2%
1M-17.5%
3M+74.7%
6M+12.7%
YTD+31.5%
1Y-2.0%
3Y-33.1%
52-Week Trading Range38% from low
$8.98
52W Low$0.20
52W High$23.22

Technical Indicators

RSI (14)NEUTRAL
51.3
305070
VCP ScoreCOOL
3/10
Base depth: 207.1%

Risk Profile

Beta
0.89
52W Vol
174%
ATR
$1.04
Max DD (1Y)
-98%

Volume Analysis

Today
43.9K
50D Avg
323.9K
Vol Ratio
0.14x
Liquidity
MODERATE

Earnings Momentum

Q3'23-300%
$-0.60
Q4'23+4%
$-1.05
Q1'24-25%
$-0.75
Q2'24-20%
$-0.90
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:+170.36%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:-27.02%

Stock Price CAGR

10 Years:-0.88%
5 Years:-1.65%
3 Years:-33.11%
1 Year:-1.97%

Return on Equity

10Y Avg:-244.4%
5Y Avg:-244.4%
3Y Avg:-485.5%
Last Year:-150.9%

Key Metrics

Market Cap$7M
Gross Margin34.2%
Net Margin-33.4%
Piotroski F-Score4/9

Frequently Asked Questions

Is MLEC in an uptrend right now?

MLEC has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is MLEC overbought or oversold?

MLEC's RSI (14) is 51. The stock is in neutral territory, neither overbought nor oversold.

Is MLEC outperforming the market?

MLEC has a Relative Strength (RS) Rating of 99 out of 99. Yes, MLEC is a market leader, outperforming 99% of all stocks over the past 12 months.

Where is MLEC in its 52-week range?

MLEC is trading at $8.98, which is 39% of its 52-week high ($23.22) and 38% above its 52-week low ($0.20).

How volatile is MLEC?

MLEC has a Beta of 0.89 and 52-week volatility of 174%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.